VGTI Florida
Port Saint Lucie, Florida, United States
About VGTI Florida
VGTI Florida researchers are studying the human immune system with the goal of understanding the mechanisms and pathways that are responsible for our response to pathogens and cancer. Our research is therefore ultimately directed toward preventing and treating infectious diseases, cancer and boosting immunity of the elderly. We are working in collaboration, locally and globally, with others on developing new vaccines and treatments to fight diseases such as HIV/AIDS, breast and ovarian cancer, and influenza as well as emerging infectious diseases such as Yellow Fever, West Nile Virus, and Dengue Fever.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $3.6M
- Last round: Grant (Jul 2013)
- Website: vgtifl.org
- Phone: 7723450614
Industries & Categories
Biotechnology, Elderly, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/vgti-florida-2602187 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.